Common names in 20 European languages →
The complete database record: 3 documented constituents, 5 traditional / indicated uses, with 20 cited sources.
Botanical Description
Deciduous shrub or small tree with slender, aromatic, palmately compound leaves of narrow, lance-shaped leaflets, greyish-downy beneath. Small, fragrant, lilac to violet flowers are borne in long, slender terminal spikes, followed by small, dark, peppercorn-like berries with a peppery, aromatic taste.[1]
Habitat & Distribution
Native to the Mediterranean region and Central Asia, growing along riverbanks, streamsides and coastal scrub; widely cultivated in warm-temperate climates worldwide.[1]
Harvesting
The ripe berries are collected in autumn once they have darkened and dried, then further dried and stored for use in decoctions or standardised extracts.
Key Constituents
Bind dopamine D2 receptors in the pituitary, reducing prolactin release - the key mechanism.
Traditional & Indicated Uses
Eases cyclical breast pain (mastalgia) and menstrual-cycle complaints including cramping. The proposed mechanism is dopaminergic suppression of latent hyperprolactinaemia.
Eases cyclical breast pain (mastalgia) and menstrual-cycle complaints including cramping; Relief of premenstrual syndrome (PMS) symptoms
more plants for pms / premenstrual syndrome →detailed sources →
Traditional Use & History
Chasteberry has a long Mediterranean tradition, reflected in its 'chaste tree' name, historically used to reduce libido in monastic settings, and, more centrally to its modern use, as a traditional women's tonic for menstrual irregularities, premenstrual complaints and cyclical breast tenderness; standardised extracts are now among the best-clinically-studied herbal remedies for premenstrual syndrome, acting via dopaminergic modulation of prolactin.[1]
Preparations
Dried fruit extract standardised to agnuside/casticin content, taken as tablets or capsules; the form used in most clinical PMS and cyclical breast pain trials.
Dosage
Clinical trials for PMS commonly use extracts providing around 20-40 mg of dried fruit extract daily, taken over several menstrual cycles for full effect. Educational reference only, not a prescription.
Safety, Cautions & Contraindications
Reported adverse events are mild and reversible (nausea, headache, gastrointestinal upset, menstrual changes, acne, itching or rash).
Because it acts on dopamine and the hormonal axis, avoid alongside dopamine-antagonist (antipsychotic) or dopamine-agonist drugs and use caution with hormonal medicines (oral contraceptives, HRT) and hormone-sensitive conditions.
Avoid during pregnancy and breastfeeding. A systematic review found only poor-grade evidence (theoretical, expert opinion and in vitro) suggesting oestrogenic, progesteronic, uterine-stimulant and emmenagogue activity, and expert opinion actively conflicts on whether chastetree increases or decreases lactation. The precaution rests on absence of safety data rather than on demonstrated harm.
Harvest Readiness
External Identifiers
References & Sources
- van Die, M.D., Burger, H.G., Teede, H.J. and Bone, K.M (2012) 'Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials', Planta Medica. doi:10.1055/s-0032-1327831 Meta-analysis / review
https://doi.org/10.1055/s-0032-1327831 - Csupor, D., Lantos, T., Hegyi, P., Benko, R. and others (2019) 'Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials', Complementary Therapies in Medicine, 47, pp. 102190. doi:10.1016/j.ctim.2019.08.024 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2019.08.024 - Verkaik, S., Kamperman, A.M., van Westrhenen, R. and Schulte, P.F.J (2017) 'The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis', American Journal of Obstetrics and Gynecology, 217(2), pp. 150-166. doi:10.1016/j.ajog.2017.02.028 Meta-analysis / review
https://doi.org/10.1016/j.ajog.2017.02.028 - Ooi, S.L., Watts, S., McClean, R. and Pak, S.C (2020) 'Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis', Journal of Women's Health, 29(2), pp. 262-278. doi:10.1089/jwh.2019.7770 Meta-analysis / review
https://doi.org/10.1089/jwh.2019.7770 - Holler, M., Steindl, H., Abramov-Sommariva, D., Kleemann, J. and others (2024) 'Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study', Archives of Gynecology and Obstetrics, 309(5), pp. 2089-2098. doi:10.1007/s00404-023-07363-4 Clinical study
https://doi.org/10.1007/s00404-023-07363-4 - Cerqueira, R.O., Frey, B.N., Leclerc, E. and Brietzke, E (2017) 'Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review', Archives of Women's Mental Health, 20(6), pp. 713-719. doi:10.1007/s00737-017-0791-0 Meta-analysis / review
https://doi.org/10.1007/s00737-017-0791-0 - van Die, M.D., Burger, H.G., Teede, H.J. and Bone, K.M (2009) 'Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints', Journal of Alternative and Complementary Medicine, 15(8), pp. 853-862. doi:10.1089/acm.2008.0447 Meta-analysis / review
https://doi.org/10.1089/acm.2008.0447 - Daniele, C., Thompson Coon, J., Pittler, M.H. and Ernst, E (2005) 'Vitex agnus castus: a systematic review of adverse events', Drug Safety. doi:10.2165/00002018-200528040-00004 Meta-analysis / review
https://doi.org/10.2165/00002018-200528040-00004 - Wuttke, W., Jarry, H., Christoffel, V., Spengler, B. and Seidlova-Wuttke, D (2003) 'Chaste tree (Vitex agnus-castus) - pharmacology and clinical indications', Phytomedicine, 10(4), pp. 348-357. doi:10.1078/094471103322004866 Meta-analysis / review
https://doi.org/10.1078/094471103322004866 - Kuruzum-Uz, A., Stroch, K., Demirezer, L.O. and Zeeck, A (2003) 'Glucosides from Vitex agnus-castus', Phytochemistry, 63(8), pp. 959-964. doi:10.1016/s0031-9422(03)00285-1 Preclinical
https://doi.org/10.1016/s0031-9422(03)00285-1 - Rani, A. and Sharma, A (2013) 'The genus Vitex: A review', Pharmacognosy Reviews, 7(14), pp. 188-198. doi:10.4103/0973-7847.120522 Traditional / reference
https://doi.org/10.4103/0973-7847.120522 - Mollazadeh, S. and Mirghafourvand, M. and Abdollahi, N. G (2019) 'The effects of Vitex agnus-castus on menstrual bleeding: a systematic review and meta-analysis', Journal of Complementary and Integrative Medicine, 17(1). doi:10.1515/jcim-2018-0053 Meta-analysis / review
https://doi.org/10.1515/jcim-2018-0053 - Tha\c ci, S. and Krasniqi, B. and D\"ermaku-Sopjani, M. and Rifati-Nixha, A. and Abazi, S. and Sopjani, M (2022) 'Vasorelaxant effects of the Vitex agnus-castus extract', Evidence-Based Complementary and Alternative Medicine, 2022, pp. 7708781. doi:10.1155/2022/7708781 Preclinical
https://doi.org/10.1155/2022/7708781 - Puglia, L.T., Lowry, J. and Tamagno, G (2023) 'Vitex agnus castus effects on hyperprolactinaemia', Frontiers in Endocrinology. doi:10.3389/fendo.2023.1269781 Randomized trial
https://doi.org/10.3389/fendo.2023.1269781 - North Carolina State Extension 'Vitex agnus-castus - Extension Gardener Plant Toolbox'. Available at: https://plants.ces.ncsu.edu/plants/vitex-agnus-castus/ Traditional / reference
https://plants.ces.ncsu.edu/plants/vitex-agnus-castus/ - Wikipedia contributors 'Vitex agnus-castus'. Available at: https://en.wikipedia.org/wiki/Vitex_agnus-castus Traditional / reference
https://en.wikipedia.org/wiki/Vitex_agnus-castus - Zeqiri, A. and Dermaku-Sopjani, M. and Sopjani, M (2022) 'The mechanisms underlying the role of Vitex agnus-castus in mastalgia', Bratislava Medical Journal, 123(12), pp. 913--918. doi:10.4149/BLL_2022_147 Preclinical
https://doi.org/10.4149/BLL_2022_147 - Atmaca, M. and Kumru, S. and Tezcan, E (2003) 'Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder', Human Psychopharmacology, 18(3), pp. 191--195. doi:10.1002/hup.470 Randomized trial
https://doi.org/10.1002/hup.470 - Zamani, M. and Neghab, N. and Torabian, S (2012) 'Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome', Acta Medica Iranica, 50(2), pp. 101--106. Available at: https://pubmed.ncbi.nlm.nih.gov/22359078/ Randomized trial
https://pubmed.ncbi.nlm.nih.gov/22359078/ - Dugoua, J.-J. and Seely, D. and Perri, D. and Koren, G. and Mills, E (2008) 'Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation', Canadian Journal of Clinical Pharmacology, 15(1), pp. e74--e79. Available at: https://pubmed.ncbi.nlm.nih.gov/18204102/ Meta-analysis / review
https://pubmed.ncbi.nlm.nih.gov/18204102/
Selected studies & references
All 18 studies in the Knowledge Finder →
This profile is assembled automatically from the Omnia Sana plant database, which we curate by hand. How this site is built.